Table 1.
N | 85 |
Age, median (IQR) | 75 (63–81) |
Female sex | 41 (48%) |
M1 occlusion of CT | 66 (78%) |
NIHSS, median (IQR) | 16 (11–20) |
History of ischemic stroke | 18 (21%) |
History of hypertension | 42 (50%) |
History of diabetes melitus | 8 (9%) |
Prestroke mRS | |
0 | 60 (70%) |
1 | 11 (13%) |
≥2 | 14 (17%) |
RR systolic in mmHg, median (IQR) | 144 (130–160) |
Treatment with IV-rtPA | 62 (73%) |
ASPECTS, median (IQR) | 9 (9–10) |
CTA collateral score | |
0 | 4 (15%) |
1 | 37 (43%) |
2 | 37 (43%) |
3 | 7 (9%) |
eTICI | |
0 | 13 (15%) |
1 | 4 (5%) |
2A | 16 (19%) |
2B | 14 (16%) |
2C | 13 (15%) |
3 | 25 (30%) |
General anesthesia | 7 (8%) |
Onset-to-groin puncture time in min, median (IQR) | 150 (118–211) |
EVT time in min, median (IQR) | 52 (31–81) |
IQR indicates interquartile range; M1, M1 segment of middle cerebral artery; eTICI, extended treatment in cerebral ischemia; and EVT, endovascular treatment.